« Back to Record
Heinrichs, A., Dessars, B., El Housni, H., Pluymers, W., Peeters, K., Benghiat, F., & Heimann, P. (2018). Identification of chronic myeloid leukemia patients treated with imatinib who are potentially eligible for treatment discontinuation by assessing real-life molecular responses on the international scale in a EUTOS-certified lab. Leukemia research, 67, 27-31. doi:10.1016/j.leukres.2018.01.018
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/268399



